title: [A case of cholangiocarcinoma with marked reduction of tumor after oral administration of UFT].
abstract: A 54-year-old male complaining mainly of pain in the right terminal rib area was admitted to hospital for hepatic tumor examination. Cholangiocarcinoma was diagnosed by various imaging techniques, and the patient was started on a program of daily oral administrations of 600 mg of UFT after abdominal arterial injection of 30 mmg of MMC. The tumor continued to decrease in size on CT image during two years of UFT administration. The patient continues to be monitored as an outpatient. A marked reduction in the size of a cholangiocarcinoma was observed in the case, and administration of UFT has proved effective in prolonging life for over two years.
authors.affiliation: Dept. of Internal Medicine, Tonan Hospital.
authors.forename: S
authors.initials: S
authors.lastname: Uehara
authors.forename: F
authors.initials: F
authors.lastname: Hirano
authors.forename: N
authors.initials: N
authors.lastname: Sakai
authors.forename: K
authors.initials: K
authors.lastname: Honjo
authors.forename: A
authors.initials: A
authors.lastname: Hirayama
authors.forename: H
authors.initials: H
authors.lastname: Moriya
mesh_terms: D002759:Adenoma, Bile Duct / Q000188:drug therapy*; D000284:Administration, Oral; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage / Q000627:therapeutic use*; D001650:Bile Duct Neoplasms / Q000188:drug therapy*; D001653:Bile Ducts, Intrahepatic; D006801:Humans; D008297:Male; D008875:Middle Aged; D005641:Tegafur / Q000008:administration & dosage / Q000627:therapeutic use; D014498:Uracil / Q000008:administration & dosage / Q000627:therapeutic use
chemical_list: D005641:Tegafur; D014498:Uracil